| Munib Yousuf, MD | |
|
219 S Washington St, Easton, MD 21601-2913 | |
| (410) 882-1000 | |
| (443) 417-1588 |
| Full Name | Munib Yousuf |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 219 S Washington St, Easton, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326571605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0090133 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Shore Medical Center At Easton | Easton, MD | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| University Of Md Shore Medical Ctr At Chestertown | Chestertown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shore-bayy Hospitalists Associates | 3375835390 | 37 |
| Hospitalist Medicine Physicians Of Virginia Llc | 5698842235 | 116 |
News Archive
A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
› Verified 3 days ago
| Entity Name | Chester River Hospital Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679536809 PECOS PAC ID: 0749220671 Enrollment ID: O20050510000504 |
News Archive
A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
› Verified 3 days ago
| Entity Name | Shore-bayy Hospitalists Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548618671 PECOS PAC ID: 3375835390 Enrollment ID: O20160713000038 |
News Archive
A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Munib Yousuf, MD Po Box 2700, Easton, MD 21601-8952 Ph: (410) 822-1000 | Munib Yousuf, MD 219 S Washington St, Easton, MD 21601-2913 Ph: (410) 882-1000 |
News Archive
A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
› Verified 3 days ago
Anish M. Hinduja, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Martin Court, Easton, MD 21601 Phone: 410-820-9823 Fax: 866-606-6428 | |
Dr. Roshan Bisural, Internal Medicine Medicare: Medicare Enrolled Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 | |
Dr. Michael Patrick Moran, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 556 Cynwood Drive, Suite A, Easton, MD 21601 Phone: 410-221-1185 Fax: 410-221-1187 | |
Dr. Carolyn R Helmly, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 508 Idlewild Ave, Easton, MD 21601 Phone: 410-822-9133 Fax: 410-822-9513 | |
Elizabeth Smelter Clayton, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Dutchmans Ln, Suite A2, Easton, MD 21601 Phone: 410-819-6545 Fax: 410-819-6750 | |
Pratibha Phuyal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 | |
Robert Bruce Helmly, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Cadmus Ln Ste 207, Easton, MD 21601 Phone: 410-822-5571 Fax: 410-822-3859 |